Rational design and synthesis of novel nucleotide anti-Giardia agents

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 7, 2007, Pages 2064-2067

  Suk, Dae Hwan ^a   Bonnac, Laurent ^a   Dykstra, Christine C ^b   Pankiewicz, Krzysztof W ^a   Patterson, Steven E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Anti Giardia drug; Cyst wall synthesis; Giardiasis; Nucleotide

Indexed keywords

ANTIPARASITIC AGENT; CHITIN SYNTHASE; METRONIDAZOLE; NUCLEOTIDE; URIDINE DIPHOSPHATE N ACETYLGALACTOSAMINE;

ARTICLE; DRUG DESIGN; DRUG SENSITIVITY; DRUG SYNTHESIS; GIARDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TROPHOZOITE;

ACETYLGALACTOSAMINE; ANIMALS; ANTIPROTOZOAL AGENTS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL WALL; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; GIARDIA; HUMANS; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; NUCLEOTIDES; TROPHOZOITES; WATER;

GIARDIA;

EID: 33847643327     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.01.014     Document Type: Article

References (26)

1. WHO, Protozoan parasites (Cryptosporidium, Giardia, Cyclospora). In Guidelines for Drinking Water Quality, 2002; World Health Organization: Geneva, pp 70-118.
2. WHO, Microbial Fact Sheets. In Guidelines for Drinking Water, 2003; World Health Organization: Geneva, pp 221-296.
3. Gajadhar A.A., and Allen J.R. Vet. Parasitol. 126 (2004) 3
4. Thompson R.C. Vet. Parasitol. 126 (2004) 15
5. Ali S.A., and Hill D.R. Curr. Opin. Infect. Dis. 16 (2003) 453
6. Okhuysen P.C. Clin. Infect. Dis. 33 (2001) 110
7. Wright J.M., Dunn L.A., Upcroft P., and Upcroft J.A. Expert Opin. Drug Saf. 2 (2003) 529
8. Schuster F.L., and Visvesvara G.S. Int. J. Parasitol. 34 (2004) 1001
9. Schuster F.L., and Visvesvara G.S. Drug Resist. Updat. 7 (2004) 41
10. Adagu I.S., Nolder D., Warhurst D.C., and Rossignol J.F. J. Antimicrob. Agents Chemother. 49 (2002) 103
11. Smith H., and Nichols R.A. Parassitologia 48 (2006) 101
12. Polley L. Int. J. Parasitol. 35 (2005) 1279
13. Jarroll E.L., and Sener K. Drug Resist. Updat. 6 (2003) 239
14. Metronidazole inhibits cyst formation but this is secondary to its mechanism of action.
15. Gillin F.D., Reiner D.S., and McCaffery J.M. Annu. Rev. Microbiol. 50 (1996) 679
16. Karr C.D., and Jarroll E.L. Microbiology 150 (2004) 1237
17. Coppin A., Dzierszinski F., Legrand S., Mortuaire M., Ferguson D., and Tomavo S. Biochimie 85 (2003) 353
18. Chavez-Munguia B., Hernandez-Ramirez V., Angel A., Rios A., Talamas-Rohana P., Gonzalez-Robles A., Gonzalez-Lazaro M., and Martinez-Palomo A. Exp. Parasitol. 107 (2004) 39
19. Harris J.R., and Petry F. J. Parasitol. 85 (1999) 839
20. Schramm V.L. Curr. Opin. Struct. Biol. 15 (2005) 604
21. Stolz F., Blume A., Hinderlich S., Reutter W., and Schmidt R.R. Eur. J. Org. Chem. (2004) 3304
22. Schafer A., and Thiem J. J. Org. Chem. 65 (2000) 24
23. Blackburn G. Chem. Ind. (1981) 131
24. Pankiewicz K., and Goldstein B.M. Inosine Monophosphate Dehydrogenase A Major Therapeutic Target. In: Pankiewicz K., and Goldstein B.M. (Eds). ACS Symposium Series No. 839 (2003), Oxford University Press 1-17
25. Jones G.H., and Moffatt J.G. J. Am. Chem. Soc. 90 (1968) 5337
26. Bell C.A., Dykstra C.C., Naiman N.A., Cory M., Fairley T.A., and Tidwell R.R. Antimicrob. Agents Chemother. 37 (1993) 2668